Showing entries 1 to 3 of 5
Liestal, Switzerland, August 13, 2010 - Santhera Pharmaceuticals (SIX: SANN) announced today that the European Patent Office granted patent protection for the use of idebenone (brand name CatenaŽ/SovrimaŽ) in the treatment of Duchenne Muscular Dystrophy and other muscular dystrophies.
Some friends of ours are doing the Great Kindrochit Quadrathlon at Loch Tay on Saturday the 11th July for Action Duchenne.
Well we all managed to get safely up and down Ben Nevis last Saturday. We went from sunshine and t-shirts at the bottom to hats, gloves and waterproofs at the top because of the snow and freezing temperatures. Looking forward to trying a smaller Ben next year!!